SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011275
Filing Date
2021-08-11
Accepted
2021-08-11 16:01:51
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210630x10q.htm   iXBRL 10-Q 2095958
2 EX-31.1 tmb-20210630xex31d1.htm EX-31.1 12731
3 EX-31.2 tmb-20210630xex31d2.htm EX-31.2 12315
4 EX-32.1 tmb-20210630xex32d1.htm EX-32.1 8150
  Complete submission text file 0001558370-21-011275.txt   6820979

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20210630.xsd EX-101.SCH 38655
6 EX-101.CAL tmb-20210630_cal.xml EX-101.CAL 50453
7 EX-101.DEF tmb-20210630_def.xml EX-101.DEF 162680
8 EX-101.LAB tmb-20210630_lab.xml EX-101.LAB 340380
9 EX-101.PRE tmb-20210630_pre.xml EX-101.PRE 293963
10 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210630x10q_htm.xml XML 1159340
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38935 | Film No.: 211163321
SIC: 2834 Pharmaceutical Preparations